Disclosed CapitolDisclosedCapitol
Home
Plans
Chad AI
API
Sign InGet Pro

Never Miss a Trade

Get weekly trade alerts free.

Explore

  • Politician Trades
  • Politicians
  • Executive Branch
  • Companies
  • All Stocks A–Z
  • Leaderboard
  • Compare Politicians
  • Committee Portfolios
  • Chad AI

Money & Policy

  • Government Contracts
  • Lobbying
  • Legislation
  • Campaign Finance
  • Institutional (13F)
  • Whale Watch (13D)

Markets

  • Markets Overview
  • Top Companies
  • Insider Trends
  • Economic Indicators
  • Live News

Resources

  • API Access
  • Developers
  • Developer Guides
  • Data Export
  • Glossary
  • Methodology
  • Data Sources
  • How It Works

Company

  • About Us
  • Press
  • FAQ
  • Pricing
  • vs. Capitol Trades
  • Contact
  • Watchlist

Legal

  • Editorial Standards
  • Corrections
  • Disclaimers
  • Privacy
  • Terms
© 2026 Disclosed Capitol. All rights reserved.
TermsPrivacyDisclaimer
HomeTrades
ChadWatchlistAccount

NVAX

Healthcare
Novavax, Inc. · Biotechnology
Trades
19
Politicians
0
Buys
8
Sells
11
Trades
19
Politicians
0
Buys
8
Sells
11
NVAXvs S&P 500 (normalized)
|to
No price data available
NVAX S&P 500 Buy Sell
Range
PoliticianActionDescriptionAmountTradedFiled
Ro KhannaD
SellNOVAVAX INC CMN/E FIRED BY U$15K - $50KApr 24, 2026May 11, 2026
Ro KhannaD
SellNOVAVAX INC CMN$1K - $15KFeb 26, 2026Mar 9, 2026
Michael McCaulR
BuyNOVAVAX INCORPORATED CL A$15K - $50KJan 29, 2026Jun 10, 2026
Ro KhannaD
BuyNOVAVAX INC.$1K - $15KJan 16, 2026Feb 6, 2026
Ro KhannaD
SellNOVAVAX HOLDINGS INC CMN$1K - $15KJan 13, 2026Feb 6, 2026
Ro KhannaD
BuyNOVAVAX INC CMN$1K - $15KNov 10, 2025Dec 8, 2025
Ro KhannaD
SellNOVAVAX INC$15K - $50KOct 31, 2025Nov 6, 2025
Lisa McClainR
BuyNovavax AG Common Stock$1K - $15KJan 10, 2025Oct 23, 2025
Ro KhannaD
BuyNOVAVAX INC CMN$1K - $15KJul 3, 2024Aug 6, 2024
Ro KhannaD
BuyNOVAVAX CORPORATION CMN$1K - $15KMar 31, 2022Apr 1, 2022
19 trades

Novavax, Inc. (NVAX) Congressional Stock Trades

This page tracks congressional stock trading activity in Novavax, Inc. (NVAX) in the Healthcare sector. Disclosed Capitol has indexed 19 disclosed congressional trades involving NVAX. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.

As of June 2026 — Disclosed Capitol has tracked 19 disclosed congressional trades in Novavax, Inc. (NVAX) — 11:8 sell-heavy ratio — led by Ro Khanna (D).

Which members of Congress trade Novavax, Inc.?

  • Ro Khanna (D) — 17 disclosed trades in NVAX
  • Michael McCaul (R) — 1 disclosed trade in NVAX
  • Lisa McClain (R) — 1 disclosed trade in NVAX

Recent NVAX congressional trades

DatePoliticianPartyActionAmount
Apr 24, 2026Ro KhannaDSell$15,001 - $50,000
Feb 26, 2026Ro KhannaDSell$1,001 - $15,000
Jan 29, 2026Michael McCaulRBuy$15,001 - $50,000
Jan 16, 2026Ro KhannaDBuy$1,001 - $15,000
Jan 13, 2026Ro KhannaDSell$1,001 - $15,000
Nov 10, 2025Ro KhannaDBuy$1,001 - $15,000
Oct 31, 2025Ro KhannaDSell$15,001 - $50,000
Jan 10, 2025Lisa McClainRBuy$1,001 - $15,000
Jul 3, 2024Ro KhannaDBuy$1,001 - $15,000
Mar 31, 2022Ro KhannaDBuy$1,001 - $15,000

Buy vs. sell ratio & volume

Across the 19 disclosed congressional trades in Novavax, Inc. (NVAX), members of Congress have reported 8 buys and 11 sells. The average 30-day alpha vs. the S&P 500 is 3.19%.

Novavax, Inc. financial snapshot (FY2025)

For fiscal year 2025, Novavax, Inc. reported revenue of $1.12B and net income of $440.3M, per SEC filings.

Revenue
$1.12B
Operating income
$452.8M
Net income
$440.3M
Diluted EPS
$2.58
Net margin
39.2%

Most recent reported quarter: Q2 FY2026 — revenue $56.7M, net income -$53.4M.

Figures come from SEC financial statement filings. The full annual and quarterly statement history is in the Financials tab above.